Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohort
Salma Mani et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2021)
Genetic Markers in Lung Cancer Diagnosis: A Review
Katarzyna Wadowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1
Suxing Jin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
Narjust Duma et al.
MAYO CLINIC PROCEEDINGS (2019)
Cyclooxygenase-2 in cancer: A review
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Prostacyclin: A major prostaglandin in the regulation of adipose tissue development
Mohammad Sharifur Rahman
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
Rei Mizuno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases
Kyoshiro Tsuge et al.
INTERNATIONAL IMMUNOLOGY (2019)
COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
Xiao-Feng Dong et al.
CLINICAL CANCER RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer A PRISMA-compliant meta-analysis
Jiaxi Li et al.
MEDICINE (2018)
Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway
Yulin Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Single nucleotide polymorphism rs4648298 in miRNAs hsa-miR21 and hsa-miR590 binding site of COX gene is a strong colorectal cancer determinant
Meysam Mosallaei et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer
Tingting Yu et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors
Kohichi Kawahara et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
Dingzhi Wang et al.
GASTROENTEROLOGY (2015)
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer
W-T Lee et al.
ORAL DISEASES (2015)
Association between Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk: A Prospective, Case-Cohort Study of Postmenopausal Women
Sangmi Kim et al.
CANCER PREVENTION RESEARCH (2013)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4
Dawn M. Holt et al.
JOURNAL OF IMMUNOTHERAPY (2012)
SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors
Sarah M. Rausch et al.
LUNG CANCER (2012)
Epigenetic deregulation of the COX pathway in cancer
Ines Cebola et al.
PROGRESS IN LIPID RESEARCH (2012)
Prostaglandin E2-prostoglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression
Kitipong Soontrapa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients
Vikram D. Kekatpure et al.
CANCER PREVENTION RESEARCH (2009)
Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer -: Association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation
Lei Tian et al.
CANCER (2008)
Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma
Sang-Heon Kim et al.
PHARMACOGENETICS AND GENOMICS (2007)
Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell lines
Robert S. Stearman et al.
MOLECULAR CANCER RESEARCH (2007)
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model
RS Stearman et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines
LD Dwyer-Nield et al.
CARCINOGENESIS (2005)
Share Paper
